Turn Therapeutics Inc.
TTRX•NASDAQ•Healthcare•Biotechnology

About Turn Therapeutics

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOBradley Burnam
Founded2015
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Websitewww.turntherapeutics.com
Phone818 546 4011
Address
250 N Westlake Blvd Westlake Village, California 91362 United States

Corporate Identifiers

CIK0002023016
CUSIP90021W105
ISINUS90021W1053
EIN32-0456090
SIC2834

Leadership Team & Key Executives

Bradley E. Burnam
Founder, Chief Executive Officer and Director
Dr. Neilesh Shailesh Ghodadra M.D.
Chief Medical Officer and Director
Zuraiz Chaudhary
Interim Chief Financial Officer, Vice President of Finance and Chief Accounting Officer
Mohammed Zubair
Controller